Literature DB >> 19010785

A jumonji (Jarid2) protein complex represses cyclin D1 expression by methylation of histone H3-K9.

Haruki Shirato1, Satoko Ogawa, Kuniko Nakajima, Masayo Inagawa, Mizuyo Kojima, Makoto Tachibana, Yoichi Shinkai, Takashi Takeuchi.   

Abstract

Covalent modifications of histone tails have critical roles in regulating gene expression. Previously, we identified the jumonji (jmj, Jarid2) gene, the jmjC domain, and a Jmj family. Recently, many Jmj family proteins have been shown to be histone demethylases, and jmjC is the catalytic domain. However, Jmj does not have histone demethylase activity because the jmjC domain lacks conserved residues for binding to cofactors. Independently of these studies, we previously showed that Jmj binds to the cyclin D1 promoter and represses the transcription of cyclin D1. Here, we show the mechanisms by which Jmj represses the transcription of cyclin D1. We found that a protein complex of Jmj had histone methyltransferase activity toward histone H3 lysine 9 (H3-K9). We also found that Jmj bound to the H3-K9 methyltransferases G9a and GLP. Expression of Jmj recruited G9a and GLP to the cyclin D1 promoter and increased H3-K9 methylation. Inactivation of both G9a and GLP, but not of only G9a, inhibited the methylation of H3-K9 in the cyclin D1 promoter and repression of cyclin D1 expression by Jmj. These results suggest that Jmj methylates H3-K9 and represses cyclin D1 expression through G9a and GLP, and that Jmj family proteins can regulate gene expression by not only histone demethylation but also other histone modification.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19010785     DOI: 10.1074/jbc.M804994200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  Functional Crosstalk Between Lysine Methyltransferases on Histone Substrates: The Case of G9A/GLP and Polycomb Repressive Complex 2.

Authors:  Chiara Mozzetta; Julien Pontis; Slimane Ait-Si-Ali
Journal:  Antioxid Redox Signal       Date:  2014-12-19       Impact factor: 8.401

2.  The JARID2-PRC2 duality.

Authors:  Hans-Martin Herz; Ali Shilatifard
Journal:  Genes Dev       Date:  2010-05       Impact factor: 11.361

3.  Heterochromatic histone modifications at transposons in Xenopus tropicalis embryos.

Authors:  Ila van Kruijsbergen; Saartje Hontelez; Dei M Elurbe; Simon J van Heeringen; Martijn A Huynen; Gert Jan C Veenstra
Journal:  Dev Biol       Date:  2016-09-14       Impact factor: 3.582

4.  JARID2 inhibits leukemia cell proliferation by regulating CCND1 expression.

Authors:  Chang-Liang Su; Tao-Ran Deng; Zhen Shang; Yi Xiao
Journal:  Int J Hematol       Date:  2015-05-05       Impact factor: 2.490

5.  Jarid2 regulates hematopoietic stem cell function by acting with polycomb repressive complex 2.

Authors:  Sarah A Kinkel; Roman Galeev; Christoffer Flensburg; Andrew Keniry; Kelsey Breslin; Omer Gilan; Stanley Lee; Joy Liu; Kelan Chen; Linden J Gearing; Darcy L Moore; Warren S Alexander; Mark Dawson; Ian J Majewski; Alicia Oshlack; Jonas Larsson; Marnie E Blewitt
Journal:  Blood       Date:  2015-02-02       Impact factor: 22.113

6.  Jarid2 and PRC2, partners in regulating gene expression.

Authors:  Gang Li; Raphael Margueron; Manching Ku; Pierre Chambon; Bradley E Bernstein; Danny Reinberg
Journal:  Genes Dev       Date:  2010-02-01       Impact factor: 11.361

Review 7.  Histone demethylases and cancer.

Authors:  Sotirios C Kampranis; Philip N Tsichlis
Journal:  Adv Cancer Res       Date:  2009       Impact factor: 6.242

8.  Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor complex.

Authors:  Anne Schaefer; Srihari C Sampath; Adam Intrator; Alice Min; Tracy S Gertler; D James Surmeier; Alexander Tarakhovsky; Paul Greengard
Journal:  Neuron       Date:  2009-12-10       Impact factor: 17.173

9.  Expanding the landscape of chromatin modification (CM)-related functional domains and genes in human.

Authors:  Shuye Pu; Andrei L Turinsky; James Vlasblom; Tuan On; Xuejian Xiong; Andrew Emili; Zhaolei Zhang; Jack Greenblatt; John Parkinson; Shoshana J Wodak
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

10.  The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression.

Authors:  Yong-Jin Yang; Jeung-Whan Han; Hong-Duk Youn; Eun-Jung Cho
Journal:  Nucleic Acids Res       Date:  2009-11-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.